Can-Fite BioPharma Ltd. Employee Benefits and Share-based Compensation
Can-Fite BioPharma Ltd. (CANF) reported Employee Benefits and Share-based Compensation of $141.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Notes › Compensation Related Costs
us-gaap:EmployeeBenefitsAndShareBasedCompensation · last filed 2026-03-26
| Period end | Employee Benefits and Share-based Compensation 12 month |
|---|---|
| 2025-12-31 | $141.00K 20-F · filed 2026-03-26 |
| 2024-12-31 | $112.00K 20-F · filed 2026-03-26 |
| 2019-12-31 | $192.00K 6-K · filed 2020-06-01 |
| 2018-12-31 | $270.00K 6-K · filed 2020-06-01 |
| 2017-12-31 | $253.00K 6-K · filed 2020-06-01 |